Pancytopenia
Simultaneous reduction of all three cell lines. Systematic approach: peripheral smear first, then bone marrow biopsy. Think production vs destruction.
🔍 Overview
Overview
Pancytopenia = anemia + leukopenia + thrombocytopenia. Not a diagnosis but a lab finding requiring systematic workup. Framework: decreased production (marrow failure: aplastic anemia, MDS, leukemia, myelofibrosis, infiltration by solid tumor, infection, medication) vs increased destruction/sequestration (hypersplenism, autoimmune, HLH, DIC). The peripheral smear is the single most important initial test -it guides the entire workup.
🧪 Workup
Workup
- Peripheral smear -the MOST important test. Blasts → leukemia. Teardrop cells + leukoerythroblastic picture → myelofibrosis/marrow infiltration. Dysplastic cells → MDS. Schistocytes → TTP/DIC. Megaloblastic → B12/folate deficiency. Normal morphology → aplastic anemia, drug-induced, viral.
- Reticulocyte count -low = production problem. High (unexpected in pancytopenia) = peripheral destruction + splenic sequestration.
- B12 + folate -megaloblastic anemia can cause pancytopenia (ineffective hematopoiesis)
- LDH, haptoglobin, indirect bilirubin -hemolysis markers
- HIV, HBV, HCV, EBV, CMV, parvovirus B19 -viral marrow suppression
- ANA, RF -autoimmune causes (Felty syndrome = RA + splenomegaly + neutropenia)
- Copper level -copper deficiency mimics MDS (sideroblastic anemia + neutropenia)
- Flow cytometry -if blasts or abnormal lymphocytes on smear
- Bone marrow biopsy + aspirate -definitive test. Hypercellular = MDS, leukemia, megaloblastic. Hypocellular = aplastic anemia. Dry tap = myelofibrosis. Granulomas = infection (TB, fungal). Send: morphology, cytogenetics, flow, iron stain, reticulin stain.
Differential Diagnosis by Mechanism
| Mechanism | Cause | Key Clue |
|---|---|---|
| Decreased Production | Aplastic anemia | Hypocellular marrow, young patient, reticulocyte count low |
| MDS | Elderly, dysplastic cells on smear, cytogenetic abnormalities | |
| Leukemia | Blasts on peripheral smear or bone marrow > 20% | |
| B12/folate deficiency | Megaloblastic changes, hypersegmented neutrophils, elevated MCV | |
| HIV | Risk factors, low CD4, direct marrow suppression | |
| Medications | Methotrexate, chemotherapy, TMP-SMX, linezolid, valproate | |
| Increased Destruction | Hypersplenism | Splenomegaly on exam/imaging, liver disease history |
| HLH | Ferritin > 10,000, fever, splenomegaly, hypertriglyceridemia | |
| TTP/HUS | Schistocytes, elevated LDH, low haptoglobin, renal failure | |
| DIC | Schistocytes, elevated D-dimer, low fibrinogen, prolonged PT/aPTT | |
| Infiltration | Myelofibrosis | Teardrop cells, dry tap, splenomegaly, leukoerythroblastic picture |
| Metastatic cancer | Known primary, leukoerythroblastic smear, bone pain | |
| Storage diseases | Gaucher (glucocerebrosidase deficiency), hepatosplenomegaly |
Peripheral Smear Findings
| Finding | Suggests |
|---|---|
| Blasts | Acute leukemia (AML or ALL), obtain flow cytometry urgently |
| Teardrop cells | Myelofibrosis, expect dry tap on aspiration, order reticulin stain on biopsy |
| Megaloblastic changes | B12 or folate deficiency, check levels, MMA, homocysteine |
| Schistocytes | TTP/HUS or DIC, check ADAMTS13, fibrinogen, D-dimer, coags |
| Hypersegmented neutrophils | B12 or folate deficiency, ≥ 5 lobes is pathologic |
| Rouleaux formation | Multiple myeloma, check SPEP, serum free light chains |
⚠ When to Do Bone Marrow Biopsy
- Unexplained pancytopenia after initial labs (smear, B12, folate, HIV unrevealing)
- Suspected leukemia or MDS based on clinical picture or smear
- Blasts seen on peripheral smear
- Leukoerythroblastic picture (nucleated RBCs + immature WBCs in periphery)
- Suspected infiltrative process (myelofibrosis, metastatic disease, storage disease)
🚨 Management
Management
- Treat the underlying cause:
- B12 deficiency: IM cyanocobalamin 1000 mcg daily × 7 → weekly × 4 → monthly. Pancytopenia resolves within weeks.
- Drug-induced: Stop offending agent (methotrexate, chemotherapy, TMP-SMX, linezolid, valproate). Recovery in 1-3 weeks typically.
- Aplastic anemia: Age < 40 + matched sibling donor → allogeneic stem cell transplant. Older patients → immunosuppressive therapy: horse ATG + cyclosporine + eltrombopag. RACE, 2022
- MDS: Risk stratify (IPSS-R). Low-risk → ESA, lenalidomide (del5q). High-risk → azacitidine [AZA-001] or transplant if eligible.
- Leukemia: Induction chemotherapy per subtype. APL = ATRA + arsenic trioxide (curative in > 90%).
- HLH: Etoposide-based protocol (HLH-2004). Dexamethasone. Cyclosporine. Treat trigger.
- Supportive care: pRBC for Hgb < 7 (or < 8 symptomatic). Platelets if < 10K or bleeding. Neutropenic precautions if ANC < 500. G-CSF if severe neutropenia with infection.
💊 Medications
Medications
| Drug | Dose | Route | Notes |
|---|---|---|---|
| Cyanocobalamin | 1000 mcg IM daily × 7d | IM | B12 deficiency. Expect retic crisis at day 5-7. Monitor K⁺ (drops with new cell production). |
| Horse ATG (ATGAM) | 40 mg/kg/day × 4 days | IV | Aplastic anemia immunosuppression. Give with steroids (serum sickness prophylaxis). Scheinberg, 2011 |
| Cyclosporine | 5-6 mg/kg/day divided BID | PO | With ATG for aplastic anemia. Target trough 200-400. Nephrotoxicity, HTN, tremor. |
| Eltrombopag | 150 mg daily | PO | Added to ATG+CsA in aplastic anemia improves response. RACE, 2022 |
| Azacitidine | 75 mg/m² SQ × 7 days q28d | SQ | High-risk MDS. Delays AML transformation. AZA-001, 2009 |
| Lenalidomide | 10 mg daily × 21/28 days | PO | MDS with del(5q). 67% transfusion independence. VTE prophylaxis required. |
| Filgrastim (G-CSF) | 5 mcg/kg SQ daily | SQ | Severe neutropenia with infection. Not for chronic use in MDS (may accelerate AML). |
🏥 Rounds
Pimp Questions
❓ What does a "dry tap" on bone marrow aspiration suggest?
A dry tap means the aspirate needle is correctly positioned but no marrow can be drawn. This occurs when the marrow space is replaced by fibrosis (myelofibrosis), packed with tumor cells (metastatic carcinoma, hairy cell leukemia), or in rare cases of severely aplastic marrow. The key next step is a core biopsy, this provides a tissue architecture sample even when aspiration fails. Reticulin and trichrome stains on the core biopsy will confirm fibrosis. Always suspect myelofibrosis when you see teardrop cells on smear + dry tap + splenomegaly.
❓ How do you differentiate aplastic anemia from MDS?
This is one of the most challenging distinctions in hematology. Key differences: Aplastic anemia → hypocellular marrow with normal morphology, no dysplasia, no increased blasts, younger patients, often responds to immunosuppression. Hypoplastic MDS → hypocellular marrow BUT with dysplastic changes (pseudo-Pelger-Huet cells, ring sideroblasts), cytogenetic abnormalities (especially -7, +8, del20q), and may have increased blasts. Cytogenetics is the key differentiator: present in ~50% of MDS but normal in aplastic anemia. Some cases require serial monitoring because aplastic anemia can evolve into MDS over time.
❓ What is the single most important initial test in pancytopenia?
Peripheral blood smear. It guides the entire workup: blasts (leukemia), teardrops (myelofibrosis), schistocytes (TTP/DIC), megaloblastic changes (B12/folate), dysplastic cells (MDS), normal morphology (aplastic anemia, viral, drug-induced).
❓ How can B12 deficiency cause pancytopenia?
B12 is required for DNA synthesis. Deficiency causes ineffective hematopoiesis -cells are produced but destroyed before release (intramedullary hemolysis). All three cell lines affected. The marrow is actually hypercellular (not empty) -megaloblastic precursors are dying before maturation. This can mimic MDS.
❓ What is a "dry tap" on bone marrow aspiration and what does it suggest?
A dry tap = inability to aspirate marrow despite proper needle placement. Classic for myelofibrosis (marrow replaced by reticulin/collagen fibrosis). Also seen in hairy cell leukemia, metastatic carcinoma (packed marrow), and some cases of aplastic anemia. Core biopsy is essential when aspirate fails.
❓ What electrolyte must you monitor when starting B12 repletion?
Potassium. As new red blood cells are rapidly produced (reticulocyte crisis), potassium shifts intracellularly. This can cause severe hypokalemia -potentially fatal if not monitored and repleted. Also monitor phosphate and magnesium for the same reason.
❓ Name a non-hematologic cause of pancytopenia that is commonly missed.
Copper deficiency. Causes sideroblastic anemia + neutropenia ± thrombocytopenia. Mimics MDS on smear and marrow. Risk factors: gastric bypass surgery, zinc supplementation (zinc competes with copper absorption), malnutrition, TPN without copper. Serum copper and ceruloplasmin are low. Responds to copper supplementation.
❓ What is HLH and how does it present?
Hemophagocytic lymphohistiocytosis (HLH) -uncontrolled immune activation with macrophage phagocytosis of blood cells. Presents with: persistent fever, splenomegaly, pancytopenia, hyperferritinemia (> 500, often > 10,000), hypertriglyceridemia, hypofibrinogenemia, elevated soluble IL-2 receptor. Triggers: infection (EBV), malignancy (lymphoma), autoimmune. Fatal without treatment -etoposide-based protocol. [HLH-2004]
Clinical Examples
📋 Case 1, Aplastic Anemia
Patient: 25F presenting with fatigue, easy bruising, and recurrent infections over 3 months.
Labs: WBC 1.2, Hgb 6.8, Plt 15K, reticulocyte count 0.2% (inappropriately low), MCV 98.
Peripheral smear: Pancytopenia with normal morphology, no blasts, no dysplasia, no schistocytes.
Workup:
- B12, folate, HIV, hepatitis panel, all normal
- LDH and haptoglobin, normal (no hemolysis)
- Flow cytometry, no PNH clone
- Bone marrow biopsy: markedly hypocellular (< 10% cellularity), fat-predominant, no blasts, no fibrosis
Diagnosis: Severe aplastic anemia (SAA), meets criteria: ANC < 500, Plt < 20K, retic < 1% with hypocellular marrow.
Treatment: No matched sibling donor → started on horse ATG + cyclosporine + eltrombopag. Supportive care with irradiated, leukoreduced blood products. Neutropenic precautions.
📋 Case 2, Megaloblastic Anemia (B12 Deficiency)
Patient: 68M presenting with progressive fatigue, paresthesias in both feet, and unsteady gait over 6 months.
Labs: WBC 3.1, Hgb 7.2, Plt 95K, MCV 112 (markedly elevated), reticulocyte count 0.8%.
Peripheral smear: Oval macrocytes, hypersegmented neutrophils (6-lobed), anisocytosis, poikilocytosis.
Workup:
- B12: < 100 pg/mL (severely low, normal > 300)
- Methylmalonic acid: elevated (confirms tissue B12 deficiency)
- Homocysteine: elevated
- Anti-intrinsic factor antibodies: positive → pernicious anemia
Diagnosis: Megaloblastic pancytopenia from B12 deficiency (pernicious anemia). No bone marrow biopsy needed, smear + B12 level diagnostic.
Treatment: IM cyanocobalamin 1000 mcg daily × 7 days → weekly × 4 → monthly for life. Reticulocyte crisis at day 5. Monitor K⁺ closely. Neuro symptoms may take months to improve.
📋 Case 3, Myelofibrosis
Patient: 72F presenting with early satiety, weight loss, night sweats, and progressive fatigue over 4 months.
Exam: Massive splenomegaly (palpable 8 cm below costal margin).
Labs: WBC 2.4, Hgb 8.5, Plt 68K, LDH elevated.
Peripheral smear: Teardrop cells (dacrocytes), nucleated RBCs, immature myeloid precursors, classic leukoerythroblastic picture.
Workup:
- Bone marrow aspiration: dry tap, unable to aspirate despite multiple attempts
- Core biopsy: extensive reticulin and collagen fibrosis, megakaryocyte atypia, osteosclerosis
- JAK2 V617F mutation: positive
- DIPSS-Plus risk score: intermediate-2
Diagnosis: Primary myelofibrosis (PMF). Dry tap + teardrop cells + leukoerythroblastic smear is the classic triad.
Treatment: Started ruxolitinib (JAK2 inhibitor) for symptom control and splenomegaly. Evaluated for allogeneic transplant given intermediate-2 risk.
Sample Presentation
Mrs. Chen is a 72-year-old woman referred for pancytopenia found on routine labs: Hgb 8.1, WBC 2.8 (ANC 900), platelets 78K. No B symptoms. No bleeding. No infections. Medications: metformin, lisinopril. Peripheral smear: macrocytosis, hypersegmented neutrophils, oval macrocytes. B12 level: 89 pg/mL (low). MMA elevated. Folate normal. Retic count 0.5%.
Key Points: Classic megaloblastic pancytopenia from B12 deficiency. Smear is diagnostic -hypersegmented neutrophils + oval macrocytes. Start IM B12 immediately. Expect reticulocyte crisis at day 5-7 and monitor K⁺ (drops with new hematopoiesis). No bone marrow biopsy needed if smear + B12 level confirm the diagnosis.
📋 Summary
Summary
Define the Problem
Anemia plus leukopenia plus thrombocytopenia together. The useful first split is failure of production versus peripheral destruction or sequestration, because that decides whether the answer is in the marrow or outside it.
The Smear Comes First
The peripheral smear is the cheapest and highest-yield test in the workup, and it frequently makes the diagnosis before the marrow is touched. Blasts mean leukemia. Hypersegmented neutrophils with a raised MCV mean B12 or folate deficiency. Schistocytes mean a microangiopathy. A leukoerythroblastic picture with teardrop cells means marrow infiltration or fibrosis. Dysplastic forms point to myelodysplastic syndrome.
Send the Reversible Causes Early
B12, folate, HIV, hepatitis serologies, TSH, LDH, haptoglobin, reticulocyte count, iron studies and copper. The reticulocyte count separates the two mechanisms: low means the marrow is not producing, high means the cells are being destroyed or lost in the periphery.
Review the Medication List Line by Line
Drugs are one of the commonest reversible causes. Methotrexate, chemotherapy, TMP-SMX, linezolid (especially beyond 2 weeks), valproate, carbamazepine, azathioprine, colchicine and alcohol. Stopping the drug is both the test and the treatment, and counts usually recover within days to weeks.
When the Marrow Biopsy Is Indicated
Unexplained pancytopenia after the initial labs, blasts on the smear, a leukoerythroblastic picture, or a clinical suspicion of leukemia or myelodysplasia. Aspirate and trephine together with cytogenetics and flow cytometry, because the cellularity itself is the answer: hypocellular suggests aplastic anemia, hypercellular suggests ineffective hematopoiesis as in myelodysplasia or megaloblastic anemia.
Do Not Forget the Spleen
Splenomegaly with pancytopenia is sequestration until proven otherwise, most often from cirrhosis with portal hypertension. The marrow here is normal, so a biopsy in an obviously cirrhotic patient with a large spleen adds risk without adding information.
Two Diagnoses Not to Miss
Acute leukemia, which is a treatment emergency, and hemophagocytic lymphohistiocytosis, where fever, splenomegaly, very high ferritin, high triglycerides and low fibrinogen accompany the cytopenias and untreated mortality is high. Also consider PNH when hemolysis and thrombosis accompany the cytopenias, since flow cytometry diagnoses it and a specific therapy exists.
Manage the Consequences While You Investigate
Neutropenic fever is a medical emergency: cultures and broad-spectrum antibiotics within 1 hour, before any imaging. Transfuse platelets below 10,000, or below 50,000 with bleeding or before a procedure. Use a restrictive red cell threshold. Use irradiated and leukoreduced products where a transplant is possible, and avoid transfusing a potential donor's relatives' blood, since sensitization compromises later engraftment.
📄 One Pager
Text version
One-Pager
Pancytopenia
Systematic Approach
Workup Algorithm
Step 1: Peripheral smear (most important). Step 2: Retic count (production vs destruction). Step 3: B12, folate, HIV, HCV, copper. Step 4: Bone marrow biopsy if not explained by above.
Common Causes by Smear
Blasts → leukemia. Teardrops → myelofibrosis. Megaloblastic → B12/folate. Dysplastic → MDS. Schistocytes → TTP. Normal → aplastic anemia, drug, viral.
Trials
RACE 2022 (ATG+CsA+eltrombopag for AA) · AZA-001 2009 (azacitidine for MDS) · HLH-2004 (etoposide protocol) · Scheinberg 2011 (horse vs rabbit ATG)
Related Topics
Acute Leukemia (AML / ALL)AmyloidosisAnemia WorkupAnemia WorkupAnticoagulation ManagementChemotherapy Toxicities